Advertisement

Topics

Companies Related to "Targeted Naltrexone for Problem Drinkers" [Most Relevant Company Matches] RSS

06:21 EST 16th February 2019 | BioPortfolio

Here are the most relevant search results for "Targeted Naltrexone for Problem Drinkers" found in our extensive corporate database of over 50,000 company records.

Showing "Targeted Naltrexone Problem Drinkers" Companies 1–25 of 867

Relevant

Behavior Therapy Associates LLP

Our Research Division is involved in research primarily in alcohol and drug problems. We have ongoing research projects and contracts to train counselors in evidence based protocols.As a result of our research and training activities we have developed a number of products in which you might be interested. These include software programs and web applications that motivate problem drinkers to change...


Topix.net

Topix.net was founded in 2002 with the specific mission of providing users the ability to quickly and easily find targeted news on the Internet. With thousands of news sources continually releasing stories twenty-four hours a day, finding relevant news can often be a time consuming task. For complete coverage, users are forced to visit many different sites and sift through a variety of stories tha...

Targeted Genetics Corporation

Targeted Genetics Corporation is a biotechnology company committed to the development and commercialization of innovative therapies for the prevention and treatment of diseases with significant unmet medical need. To learn more about Targeted Genetics, visit Targeted Genetics' website at www.targetedgenetics.com.


ERI® System

The ERI® is a quality tool that has helped us in the interview and during reference checking to identify and respond to possible problem areas that the candidate may have. The system has helped us to structure and focus the interview to explore any possible problem areas identified by the ERI®."

Fresh Start Private Management, Inc.

Fresh Start Private Management (http://www.freshstartprivate.com/) is an alcohol addiction, alcohol withdrawal, alcohol abuse treatment and alcohol detox rehabilitation company. The company has licensed a treatment that delivers target therapeutic levels of Naltrexone that reduce patients' cravings for alcohol.

CoverAid

Co Founded by Dr. Scott Gritz and Dr. Steve Rotter, CoverAid is the solution to camouflaging facial lesions while providing therapeutic relief at the source. Instead of piling on layers of makeup, messy creams, or cakey formulas, which can irritate an already damaged complexion, CoverAid’s three unique brands targeted at lips, skin, and scars, help pr...

Probably Relevant

The Coleman Institute

Since 1998, The Coleman Institute has helped hundreds of patients detoxify and recover from the effects of heroin use and other narcotics such as Methadone, Oxycontin, Percocet, and Vicodin. The Coleman Institute's Accelerated Detoxification Technique combined with Naltrexone therapy makes it unique among addiction treatment methods and leads it to achieve higher success rates than other addiction...

Sleep HealthCenters®, Inc.

It is estimated that at least 40 million Americans suffer from a chronic sleep disorder or intermittent sleep-related problem. Sleep deprivation is an unhealthy, dangerous and costly problem.Sleep HealthCenters® is a recognized network of specialized sleep medicine centers, staffed by experts in the field of sleep medicine. Sleep HealthCenters® utilizes the most current technologies available to...

Pharmaceutica Limited

Pharmaceutica Limited is a privately owned pharmaceutical company founded in March 2003, to discover and develop a new generation of anti-infective drug technologies that combat the increasing problem caused by the rapid evolution of resistance by pathogenic organisms. The company is targeting both human and veterinary applications for its technologies.The initial focus is to find a solution to th...

Affibody

Affibody has developed a unique pipeline of affinity ligands in oncology, covering the entire value chain from research reagents to molecular imaging agents and targeted therapeutics. The company has obtained outstanding clinical molecular imaging results and promising targeted therapeutics pre-clinical results. Affibody expects to launch one molecular imaging agent per year from 2007 and to file ...

U3 Pharma AG

U3 Pharma AG is an emerging leader in targeted cancer drug development. The company has produced a pipeline of novel targeted therapeutics based on the ground-breaking discoveries made by its founder - Prof. Axel Ullrich.U3 Pharma´s vision is to provide clinical oncologists with an arsenal of new targeted therapeutics that can be employed to turn cancer. an often life threatening disease, into a ...

Ensysce Biosciences, Inc.

Ensysce Biosciences, San Diego, CA, is an integrated drug delivery company for both small and large molecules. To overcome the major problem of non-medical use of opioid products, Ensysce is using its prodrug technology to improve abuse deterrent properties. The BIO-MD™ prodrug abuse deterrent and MPAR™ overdose resistant pain platforms, with wor...

Divergence Inc.,

Divergence Inc., a world leader in the application of genomics to agriculture and infectious disease, discovers and develops proprietary products for the safe and effective control of parasitic diseases. Plant parasitic nematodes are the largest unsolved pest problem in agricultural chemistry. Despite billions of dollars in annual crop damage, current means of control are limited and environmental...

FIMECS, Inc.

FIMECS, Inc. is developing a new class of targeted protein degradation therapeutics for the treatment of cancer diseases. The company is focused on creating a new class of drugs based on protein degradation for ‘undruggable’ cancer targets – a term coined by industry to describe proteins that could not be targeted pharmacologically. By integrating ...

Access Pharmaceuticals

Access Pharmaceuticals is an emerging biotechnology company focused on the development and commercialization of products using the companies targeted delivery systems to improve clinical outcomes for patients. Together with our subsidiaries we have proprietary patents or rights to a number of drug delivery platforms,Synthetic polymer targeted delivery,Vitamin mediated targeted delivery, Vitamin me...

BioCancell Therapeutics

BioCancell Therapeutics Inc. is a biopharmaceuticals corporation specializing in the development of Targeted Cancer Therapy for the treatment of numerous types of cancer. The Company's proprietary technology constitutes a novel paradigm for the targeted destruction of cancer cells, with no effect on normal surrounding tissue and no observed side effects, a...

iMed.com

Information on this site is provided for informational purposes and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing or treating a health problem or disease, or prescribing any medication. Information about each product is taken from the labels of the products or from the manuf...

Celcuity Inc.

We are a cellular analysis company that is discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. Our proprietary CELx diagnostic platform uses a patient’s living tumor cells to identify the specific abnormal cellular activity dri...

Deciphera Pharmaceuticals, Inc.,

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that limit the rate and/or durability of response to existing cancer therapies. Our small molecule drug candidates are directed against an important family of enzymes called kinases, known t...

Sequoia Pharmaceuticals, Inc.

Sequoia Pharmaceuticals discovers and develops revolutionary new treatments for viral diseases including HIV/AIDS and HCV-induced hepatitis with a focus on the growing global problem of drug-resistant infectious diseases. Most anti-infective drugs were designed to block the most prevalent form of a pathogen. Those drugs are doomed to become obsolete due to the emergence of drug-resistant mutations...

Deciphera Pharmaceuticals, Inc.

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that limit the rate and/or durability of response to existing cancer therapies. Our small molecule drug candidates are directed against an important family of enzymes called kinases, known t...

Curis, Inc.

Curis is a drug development company that is committed to leveraging its innovative signaling pathway drug technologies to seek to create new targeted small molecule drug candidates for cancer. Curis is building upon its previous experiences in targeting signaling pathways, including in the Hedgehog pathway, in its effort to develop proprietary targeted can...

Endocyte, Inc.

Endocyte is a privately held biotechnology company with headquarters in the Purdue Research Park of West Lafayette, IN. Based on the applications of Endocyte’s advanced proprietary guided drug technology, the company is working to develop new drugs and diagnostic agents to treat many types of cancer and other serious diseases. The guided drug platform...

U-Systems Inc.

CLINICAL PROBLEM: Dense Breast Tissue Increases Cancer Risk

Targeted Genetics

Targeted Genetics Corporation develops and commercializes molecular therapeutics that target the underlying cause of a variety of serious diseases that have significant unmet medical need. Our lead product candidate is being developed as a treatment for inflammatory arthritis, and additional programs target HIV/AIDS, congestive heart failure, Huntington's disease and hyperlipidemia. Our diverse...


More From BioPortfolio on "Targeted Naltrexone for Problem Drinkers"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks